Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue 
MOORESTOWN, N.J., May 08, 2017 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, today announced that Chief Financial Officer, Brian Adams, will participate in the 2017 UBS Global Healthcare Conference in New York.
Mr. Adams is scheduled to present at the conference on Tuesday, May 23, 2017 at 3:30 p.m. ET. A live audio-only webcast of the presentation will be available on the investor relations section of the Company’s website at ir.trhc.com. The archived webcast and presentation materials will also be available for 90 days at the same URL.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, please visit: www.TRHC.com.
Contact: Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 [email protected] Media Dianne Semingson 215-870-0829 [email protected]
